Choosing CAR T-Cell or Bispecifics After Standard Myeloma Therapy Exhaustion: Panel Discussion

Forgot your password?

Select specialty

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Basic Science
Podcast Series
Targeted Therapies in Lung Cancer 2023
ASCO® 2023
Lung Cancer OncTalk
Blood Cancer OncTalk
2022 Melanoma Video Library
OncTalk 2022
ASCO Lung Review 2022
ASCO and ESMO Lung Recap
2021 Targeted Therapies Patient Forum
COVID-19
Lung
Hematologic Oncology
Head and Neck
Brain
Palliative
Genitourinary
General
Breast

Playback speed

By GRACE FEATURING Aaron Goodman, Sridevi Rajeeve, Marco Ruiz

March 11, 2024

Blood Cancer OncTalk

A. Srisuwananukorn

A. Goodman, S. Rajeeve, M. Ruiz

A. Goodman, A. Taneja, T. Phillips

A. Goodman, S. Rajeeve, M. Ruiz

A. Goodman, A. Jeong, S. Rajeeve

Login

Login

Join VuMedi

GRACE

Choosing CAR T-Cell or Bispecifics After Standard Myeloma Therapy Exhaustion: Panel Discussion

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Importance of Early Management of Patients with Myelofibrosis (MF)

Multiple Myeloma 101: Facts and Fiction of the 'Myeloma Marathon'

Approach to Selecting Treatment for Myelofibrosis in 2024

Emerging Treatment Options for AL Amyloidosis

Management of AL Amyloidosis

Diagnosing AL Amyloidosis

Signs and Symptoms of AL Amyloidosis

Experts Discuss Their Approach to Auto-Transplant for Young Standard…

Oncologists' Guidance on Treating Smoldering Myeloma: Panel Discussi…

Choosing CAR T-Cell or Bispecifics After Standard Myeloma Therapy Ex…

A Summary of Efficacy and Safety Data From Bispecific Antibodies in …

The Future of Bispecific Antibodies in Myeloma

Epcoritamab in NHL - Incidence and Management of CRS

Mosunetuzumab for R/R Follicular Lymphoma

Efficacy of Epcoritamab and Glofitamab in R/R DLBCL

Updates on Bispecific Antibodies in Myeloma

Overview on Current Immunotherapy Options in Myeloma

The Impact of Transplant on Survival in Myeloma and Lymphoma

Current Utility of Autologous Bone Marrow Transplants in Myeloma and…

Overview and Logistics of Bone Marrow Transplant

The TRIANGLE Study: Ibrutinib Maintenance for MCL

3L Treatment for Mantle Cell Lymphoma

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

Tailoring Chemotherapy for Geriatric Patients With Advanced Stage Ag…

The Prevalence of Mantle Cell Lymphoma

Multiple Myeloma & Cellular Therapies: A Patient-Centric Primer

Small Molecule Targeted Therapies in AML

Considerations for Older Adults With Aggressive Lymphoma

2023 Updates on Advances in Multiple Myeloma